- Home
- Publications
- Publication Search
- Publication Details
Title
Gastric adenocarcinoma
Authors
Keywords
-
Journal
Nature Reviews Disease Primers
Volume 3, Issue -, Pages 17036
Publisher
Springer Nature
Online
2017-06-01
DOI
10.1038/nrdp.2017.36
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- It Is Time to Stop Using Epirubicin to Treat Any Patient With Gastroesophageal Adenocarcinoma
- (2017) Elena Elimova et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology
- (2017) Angela N. Bartley et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab (ONO-4538/BMS-936558) as salvage treatment after second or later-line chemotherapy for advanced gastric or gastro-esophageal junction cancer (AGC): A double-blinded, randomized, phase III trial.
- (2017) Yoon-Koo Kang et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study
- (2017) Peter C Thuss-Patience et al. LANCET ONCOLOGY
- 1058PDA PHASE I MULTI-ARM DOSE-EXPANSION STUDY OF THE ANTI-PROGRAMMED CELL DEATH-LIGAND-1 (PD-L1) ANTIBODY MEDI4736: PRELIMINARY DATA
- (2017) N.H. Segal et al. ANNALS OF ONCOLOGY
- Randomized phase II study of nimotuzumab, an anti-EGFR antibody, plus irinotecan in patients with 5-fluorouracil–based regimen-refractory advanced or recurrent gastric cancer in Korea and Japan: Preliminary results.
- (2017) Y. H. Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma
- (2016) S.-E. Al-Batran et al. ANNALS OF ONCOLOGY
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) E. C. Smyth et al. ANNALS OF ONCOLOGY
- Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer
- (2016) M. Chatterjee et al. ANNALS OF ONCOLOGY
- Long-term Quality of Life After Distal Subtotal and Total Gastrectomy
- (2016) Seung Soo Lee et al. ANNALS OF SURGERY
- Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer
- (2016) Wook Kim et al. ANNALS OF SURGERY
- Long-Term Survival in Patients with Postoperative Intra-Abdominal Infectious Complications After Curative Gastrectomy for Gastric Cancer: A Propensity Score Matching Analysis
- (2016) Keiichi Fujiya et al. ANNALS OF SURGICAL ONCOLOGY
- Yield of Staging Laparoscopy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer
- (2016) Naruhiko Ikoma et al. ANNALS OF SURGICAL ONCOLOGY
- Mechanisms for the induction of gastric cancer by Helicobacter pylori infection: aberrant DNA methylation pathway
- (2016) Masahiro Maeda et al. Gastric Cancer
- Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment
- (2016) Massimo Rugge et al. GUT
- Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report
- (2016) P Malfertheiner et al. GUT
- Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma
- (2016) Elizabeth D Thompson et al. GUT
- Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignancies
- (2016) Murali Janakiram et al. Immunotherapy
- MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia
- (2016) Simone S. Riedel et al. JOURNAL OF CLINICAL INVESTIGATION
- Multicenter double-blind randomized phase II: FOLFOX + ziv-aflibercept/placebo for patients (pts) with chemo-naive metastatic esophagogastric adenocarcinoma (MEGA).
- (2016) Peter C. Enzinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Lapatinib in Gastric Cancer: What Is the LOGiCal Next Step?
- (2016) Yelena Y. Janjigian JOURNAL OF CLINICAL ONCOLOGY
- A randomized, open-label, multicenter, adaptive phase 2/3 study of trastuzumab emtansine (T-DM1) versus a taxane (TAX) in patients (pts) with previously treated HER2-positive locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma (LA/MGC/GEJC).
- (2016) Yoon-Koo Kang et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of AZD4547 in FGFR amplified tumours: Gastroesophageal cancer (GC) cohort pharmacodynamic and biomarker results.
- (2016) Elizabeth Catherine Smyth et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
- (2016) Jin Li et al. JOURNAL OF CLINICAL ONCOLOGY
- FAST: An international, multicenter, randomized, phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without IMAB362, a first-in-class anti-CLDN18.2 antibody, as first-line therapy in patients with advanced CLDN18.2+ gastric and gastroesophageal junction (GEJ) adenocarcinoma.
- (2016) Salah-Eddin Al-Batran et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, PD-L1 expression, and clinical activity of avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with advanced gastric or gastroesophageal junction cancer.
- (2016) Hyun Cheol Chung et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated results for the advanced esophageal carcinoma cohort of the phase Ib KEYNOTE-028 study of pembrolizumab (MK-3475).
- (2016) Toshihiko Doi et al. JOURNAL OF CLINICAL ONCOLOGY
- Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial
- (2016) Nick Pavlakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial
- (2016) Yanfeng Hu et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors
- (2016) Aditya Bagrodia et al. JOURNAL OF CLINICAL ONCOLOGY
- Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC—A Randomized Phase III Trial
- (2016) J. Randolph Hecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology
- (2016) Jaffer A. Ajani et al. Journal of the National Comprehensive Cancer Network
- Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
- (2016) Kei Muro et al. LANCET ONCOLOGY
- Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial
- (2016) Kazumasa Fujitani et al. LANCET ONCOLOGY
- HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib
- (2016) Michael F. Press et al. MOLECULAR CANCER THERAPEUTICS
- Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression
- (2016) Hanane Laklai et al. NATURE MEDICINE
- PD-1 says goodbye, TIM-3 says hello
- (2016) Diana Romero Nature Reviews Clinical Oncology
- Pathogenic enablers — toxic relationships in the stomach
- (2016) Lydia E. Wroblewski et al. Nature Reviews Gastroenterology & Hepatology
- The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation
- (2016) Nikolaos Charalampakis et al. ONCOLOGY
- The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas
- (2016) D. F. Quail et al. SCIENCE
- Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
- (2016) Shohei Koyama et al. Nature Communications
- The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients
- (2016) Minghui Zhang et al. Scientific Reports
- Loss of ARID1A expression predicts poor survival prognosis in gastric cancer: a systematic meta-analysis from 14 studies
- (2016) Lin Yang et al. Scientific Reports
- Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein–Barr virus
- (2016) Priya Saju et al. Nature Microbiology
- Palbociclib (PD0332991)—a Selective and Potent Cyclin-Dependent Kinase Inhibitor
- (2016) Amy S. Clark et al. JAMA Oncology
- TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)
- (2015) Trevor Leong et al. BMC CANCER
- The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression
- (2015) Chang-Ni Lin et al. BMC CANCER
- Marital status, education, and income in relation to the risk of esophageal and gastric cancer by histological type and site
- (2015) Jesper Lagergren et al. CANCER
- Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005)
- (2015) Ramesh K. Ramanathan et al. CANCER
- Global Cancer Incidence and Mortality Rates and Trends--An Update
- (2015) L. A. Torre et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Mortality reduction from gastric cancer by endoscopic and radiographic screening
- (2015) Chisato Hamashima et al. CANCER SCIENCE
- A New B7:CD28 Family Checkpoint Target for Cancer Immunotherapy: HHLA2
- (2015) Y. Xiao et al. CLINICAL CANCER RESEARCH
- Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like Cells
- (2015) C. Yoon et al. CLINICAL CANCER RESEARCH
- Landscape of dietary factors associated with risk of gastric cancer: A systematic review and dose-response meta-analysis of prospective cohort studies
- (2015) Xuexian Fang et al. EUROPEAN JOURNAL OF CANCER
- Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma
- (2015) Patrick Tan et al. GASTROENTEROLOGY
- Helicobacter pylori Update: Gastric Cancer, Reliable Therapy, and Possible Benefits
- (2015) David Y. Graham GASTROENTEROLOGY
- Blockade of PD1 and TIM3 Restores Innate and Adaptive Immunity in Patients With Acute Alcoholic Hepatitis
- (2015) Lee J.L. Markwick et al. GASTROENTEROLOGY
- Global patterns of cardia and non-cardia gastric cancer incidence in 2012
- (2015) A Colquhoun et al. GUT
- Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis
- (2015) Jennifer M Yeh et al. GUT
- Kyoto global consensus report onHelicobacter pylorigastritis
- (2015) Kentaro Sugano et al. GUT
- False-negative rate for HER2 testing in 738 gastric and gastroesophageal junction cancers (GEC) from two global randomized clinical trials.
- (2015) David Cunningham et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer
- (2015) Yung-Jue Bang et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Biomarkers in Gastric Cancer
- (2015) Elena Elimova et al. Journal of the National Comprehensive Cancer Network
- Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
- (2015) Antoni Ribas et al. LANCET ONCOLOGY
- Macrophages are critical effectors of antibody therapies for cancer
- (2015) Kipp Weiskopf et al. mAbs
- YAP and the drug resistance highway
- (2015) Alona Keren-Paz et al. NATURE GENETICS
- Stromal contribution to the colorectal cancer transcriptome
- (2015) Claudio Isella et al. NATURE GENETICS
- The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
- (2015) Luping Lin et al. NATURE GENETICS
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- (2015) Razvan Cristescu et al. NATURE MEDICINE
- Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor
- (2015) William D. Tap et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survival Analysis of Patients with Interval Cancer Undergoing Gastric Cancer Screening by Endoscopy
- (2015) Chisato Hamashima et al. PLoS One
- Cancer Stem Cells: The Promise and the Potential
- (2015) Jaffer A. Ajani et al. SEMINARS IN ONCOLOGY
- Long-term outcomes after prophylactic bursectomy in patients with resectable gastric cancer: Final analysis of a multicenter randomized controlled trial
- (2015) Motohiro Hirao et al. SURGERY
- Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors
- (2015) A. Morello et al. Cancer Discovery
- The cancer COMPASS: navigating the functions of MLL complexes in cancer
- (2015) David J. Ford et al. Cancer Genetics
- Dietary Nitrates, Nitrites, and Nitrosamines Intake and the Risk of Gastric Cancer: A Meta-Analysis
- (2015) Peng Song et al. Nutrients
- Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy
- (2015) Ismael Riquelme et al. Oncotarget
- Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
- (2015) T. Kouo et al. Cancer Immunology Research
- CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer
- (2015) Kazumichi Yoshida et al. Cancer Medicine
- Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma
- (2015) Hans A. Schlößer et al. OncoImmunology
- Hereditary Diffuse Gastric Cancer Syndrome
- (2015) Samantha Hansford et al. JAMA Oncology
- Utility of the Proximal Margin Frozen Section for Resection of Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative
- (2014) Malcolm H. Squires et al. ANNALS OF SURGICAL ONCOLOGY
- Multicentre analysis of long-term outcome after surgical resection for gastric cancer liver metastases
- (2014) T. Kinoshita et al. BRITISH JOURNAL OF SURGERY
- Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
- (2014) Carola H. Ries et al. CANCER CELL
- Hippo Coactivator YAP1 Upregulates SOX9 and Endows Esophageal Cancer Cells with Stem-like Properties
- (2014) S. Song et al. CANCER RESEARCH
- Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein
- (2014) M. Janakiram et al. CLINICAL CANCER RESEARCH
- A Signature Predicting Poor Prognosis in Gastric and Ovarian Cancer Represents a Coordinated Macrophage and Stromal Response
- (2014) R. A. Busuttil et al. CLINICAL CANCER RESEARCH
- Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer
- (2014) Taroh Satoh et al. Gastric Cancer
- Integrative Identification of Epstein–Barr Virus–Associated Mutations and Epigenetic Alterations in Gastric Cancer
- (2014) Qiaoyi Liang et al. GASTROENTEROLOGY
- Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment ofHER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study
- (2014) Taroh Satoh et al. JOURNAL OF CLINICAL ONCOLOGY
- Different roles for p16INK4a-Rb pathway and INK4a/ARF methylation between adenocarcinomas of gastric cardia and distal stomach
- (2014) Liying Xue et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study
- (2014) Timothy Iveson et al. LANCET ONCOLOGY
- Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
- (2014) Sung Hoon Noh et al. LANCET ONCOLOGY
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity
- (2014) Daniel V.T. Catenacci Molecular Oncology
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma
- (2014) Miwako Kakiuchi et al. NATURE GENETICS
- Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
- (2014) Kai Wang et al. NATURE GENETICS
- Quality of Life in the Trastuzumab for Gastric Cancer Trial
- (2014) Taroh Satoh et al. ONCOLOGIST
- Epigenetic dysregulation in Epstein-Barr virus-associated gastric carcinoma: Disease and treatments
- (2014) Tung On Yau WORLD JOURNAL OF GASTROENTEROLOGY
- Cytotoxic T Lymphocyte Antigen-4 Blockade Enhances Antitumor Immunity by Stimulating Melanoma-Specific T-cell Motility
- (2014) T. Pentcheva-Hoang et al. Cancer Immunology Research
- Prognostic Significance of Complications after Curative Surgery for Gastric Cancer
- (2013) Takeshi Kubota et al. ANNALS OF SURGICAL ONCOLOGY
- Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
- (2013) S. R. Daigle et al. BLOOD
- Loss of TGF- Adaptor 2SP Activates Notch Signaling and SOX9 Expression in Esophageal Adenocarcinoma
- (2013) S. Song et al. CANCER RESEARCH
- Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study
- (2013) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
- (2013) Tom Waddell et al. LANCET ONCOLOGY
- Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
- (2013) Florian Lordick et al. LANCET ONCOLOGY
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation
- (2013) Luc G T Morris et al. NATURE GENETICS
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression
- (2013) Stephanie M Pyonteck et al. NATURE MEDICINE
- Gastric cancer—molecular and clinical dimensions
- (2013) Roopma Wadhwa et al. Nature Reviews Clinical Oncology
- Circulating tumour cells and cell-free DNA as tools for managing breast cancer
- (2013) Leticia De Mattos-Arruda et al. Nature Reviews Clinical Oncology
- Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
- (2013) S. K. Knutson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Significance and prognostic value of Gli-1 and Snail/E-cadherin expression in progressive gastric cancer
- (2013) Zhan-shan Wang et al. TUMOR BIOLOGY
- Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells
- (2012) Junhong Zhao et al. CANCER
- Comprehensive DNA methylation and extensive mutation analyses reveal an association between the CpG island methylator phenotype and oncogenic mutations in gastric cancers
- (2012) Jeong Goo Kim et al. CANCER LETTERS
- Organ Size Control by Hippo and TOR Pathways
- (2012) Karen Tumaneng et al. CURRENT BIOLOGY
- The benefit of mass eradication ofHelicobacter pyloriinfection: a community-based study of gastric cancer prevention
- (2012) Yi-Chia Lee et al. GUT
- Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer
- (2012) Yonghui Wu et al. GUT
- Recent Development of Gastric Cancer Prevention
- (2012) M. Kato et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- A Phase III Study of Laparoscopy-assisted Versus Open Distal Gastrectomy with Nodal Dissection for Clinical Stage IA/IB Gastric Cancer (JCOG0912)
- (2012) Kenichi Nakamura et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Fifteen-Year Effects of Helicobacter pylori, Garlic, and Vitamin Treatments on Gastric Cancer Incidence and Mortality
- (2012) Jun-Ling Ma et al. JNCI-Journal of the National Cancer Institute
- Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
- (2012) Catherine de Martel et al. LANCET ONCOLOGY
- YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29
- (2012) Karen Tumaneng et al. NATURE CELL BIOLOGY
- Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes
- (2012) Zhi Jiang Zang et al. NATURE GENETICS
- Methylation Subtypes and Large-Scale Epigenetic Alterations in Gastric Cancer
- (2012) H. Zouridis et al. Science Translational Medicine
- CpG island methylator phenotype andHelicobacter pyloriinfection associated with gastric cancer
- (2012) Ji-Bin Liu WORLD JOURNAL OF GASTROENTEROLOGY
- Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project
- (2011) C. A. Gonzalez et al. ANNALS OF ONCOLOGY
- Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer
- (2011) Junhong Zhao et al. CANCER
- The prevention of infection-associated cancers
- (2011) S. De Flora et al. CARCINOGENESIS
- Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis
- (2011) W. Kang et al. CLINICAL CANCER RESEARCH
- Time Trends of Mortality from Gastric Cancer in Europe
- (2011) Amnon Sonnenberg DIGESTIVE DISEASES AND SCIENCES
- Divergent trends for gastric cancer incidence by anatomical subsite in US adults
- (2011) M. C. Camargo et al. GUT
- Low Prevalence of Helicobacter pylori-negative Gastric Cancer among Japanese
- (2011) Taiji Matsuo et al. HELICOBACTER
- Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
- (2011) Jeeyun Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
- (2011) Zhihu Ding et al. NATURE
- Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
- (2011) Kai Wang et al. NATURE GENETICS
- Cancer of the Gastric Cardia is Rising in Incidence in an Asian Population and is Associated with Adverse Outcome
- (2011) Chris Deans et al. WORLD JOURNAL OF SURGERY
- Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria
- (2010) T. Gotoda et al. BRITISH JOURNAL OF SURGERY
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma
- (2010) C. Ralph et al. CLINICAL CANCER RESEARCH
- Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer
- (2010) Wenjing Tian et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Gastric Cancer Working Group Report
- (2010) M. Sasako et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Effective Reduction of Gastric Cancer Risk With Regular Use of Nonsteroidal Anti-Inflammatory Drugs in Helicobacter Pylori–Infected Patients
- (2010) Chun-Ying Wu et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
- (2010) Ilfet Songun et al. LANCET ONCOLOGY
- Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
- (2010) L. Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mixed-type gastric cancer and its association with high-frequency CpG island hypermethylation
- (2010) Seog-Yun Park et al. VIRCHOWS ARCHIV
- Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis
- (2009) C C Abnet et al. BRITISH JOURNAL OF CANCER
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- LONG-TERM RESULTS OF GASTRIC CANCER SCREENING USING THE SERUM PEPSINOGEN TEST METHOD AMONG AN ASYMPTOMATIC MIDDLE-AGED JAPANESE POPULATION
- (2009) Kazumasa Miki et al. Digestive Endoscopy
- Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees
- (2009) Su Youn Nam et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Epstein-Barr virus associated gastric carcinoma: Epidemiological and clinicopathological features
- (2008) Suminori Akiba et al. CANCER SCIENCE
- Molecular dissection of the chromosome band 7q21 amplicon in gastroesophageal junction adenocarcinomas identifies cyclin-dependent kinase 6 at both genomic and protein expression levels
- (2008) H. van Dekken et al. GENES CHROMOSOMES & CANCER
- The Standardized Development Method of the Japanese Guidelines for Cancer Screening
- (2008) C. Hamashima et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial
- (2008) Kazutoshi Fukase et al. LANCET
- D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer
- (2008) Mitsuru Sasako et al. NEW ENGLAND JOURNAL OF MEDICINE
- Decreased death from gastric cancer by endoscopic screening: Association with a population-based cancer registry
- (2008) Osamu Hosokawa et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started